MAPT and Alzheimer disease: As part of the Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer’s disease (KBASE), a 2017 study observed that in cognitively healthy subjects aged between 55–90, lower serum zinc levels were not related to Tau accumulation or AD-signature cerebral glucose metabolism, but were significantly associated with Aβ deposition in the brain [288].